Company Filing History:
1 out of 2 
1 out of 28 
1 out of 58 
Years Active: 2006-2012
Title: Anna Tramontano: Innovator in Biomedicine
Introduction
Anna Tramontano is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of biomedicine, particularly in the development of peptides with therapeutic applications. With a total of 2 patents, her work has the potential to impact various medical treatments.
Latest Patents
Tramontano's latest patents include innovative discoveries that focus on proangiogenic activity. One of her notable patents is titled "Peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1 having proangiogenic activity." This patent describes a sequence peptide isolated in the domain II type-immunoglobulin of the Vascular Endothelial Growth Factor receptor 1, which is useful for preparing pharmacological agents with proangiogenic activity. Another significant patent is "Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof." This patent provides peptides that are mimotopes of the hypervariable region 1 of the putative envelope protein E2 of the hepatitis C virus, which are useful in obtaining antibodies and raising an immune response cross-reactive against different strains of HCV.
Career Highlights
Throughout her career, Anna Tramontano has worked with reputable organizations, including the Italian Province of the Congregation of the Sons of the Immaculate Conception and the National Research Council of Italy. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Tramontano has collaborated with notable colleagues, including Stefania D'Atri and Cristina Maria Failla. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Anna Tramontano is a remarkable inventor whose work in biomedicine continues to pave the way for new therapeutic approaches. Her patents reflect her dedication to advancing medical science and improving patient outcomes.